2.200USD+1.85%Mkt Cap: 86.15M $P/E: —1d ago
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap86.15M $
Enterprise Value41.25M $
Revenue (TTM)57.00K $
Gross Profit-83.00K $
Net Income (TTM)-31.93M $
Revenue/Share0.0010 USD
Last Price2.200 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees71
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.82
PEG—
EV/EBITDA-1.15
EV/Revenue723.74
P/S1511.39
P/B1.27
EPS (TTM)-0.64
EPS (Forward)-0.58
52W Range
1.56027% of range3.950
52W High3.950 USD
52W Low1.560 USD
Profitability
Gross Margin-102.47%
Oper. Margin-66857.14%
EBITDA Margin0.00%
Profit Margin-39417.28%
ROE-42.34%
ROA-31.32%
Growth
Revenue Growth-63.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M $
CapEx (TTM)726.00K $
FCF Margin-33163.38%
FCF Yield-21.94%
Net Debt-44.90M $
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.03
Current Ratio2.12
Quick Ratio2.02
Book Value/Sh1.727 USD
Cash/Share1.210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.500 USD
Upside (mean)+150.0%
Target Range5.000 USD – 6.000 USD
$5.000+150.0% to mean$6.000
# Analysts2
Ownership
Shares Out.38.19M
Float27.46M
Insiders11.76%
Institutions51.03%
Short Interest
Short Ratio5.7d
Short % Float0.85%
Short % Out.0.67%
Shares Short262.55K
Short (prev mo.)297.21K
Technical
SMA 501.937 (+13.6%)
SMA 2002.580 (-14.7%)
Beta0.97
S&P 52W Chg20.25%
Avg Vol (30d)42.44K
Avg Vol (10d)35.66K
Technical Indicators
RSI (14)62.1
MACD0.0396
MACD Signal0.0096
MACD Hist.+0.0300
BB Upper2.193 USD
BB Middle1.932 USD
BB Lower1.671 USD
BB Width27.05%
ATR (14)0.1704 USD
Vol Ratio (20d)0.42x